How European countries prevent and communicate on Hantavirus infection, ECDC study
Prompted by the increase of hantavirus activity in Europe observed in 2012, ECDC report reviewed the preventive measures and communication strategies in European countries.
Surveillance, prevention and control of dengue in Madeira: lessons learnt after the 2013 ECDC mission
New report provides recommendations for surveillance, prevention and control of dengue in Madeira, following the ECDC mission to Madeira in March 2013.
New ECDC protocols for surveillance of healthcare-associated infections: targeted surveillance is an essential tool for control and prevention
Today, ECDC’s Healthcare-associated Infections Surveillance Network (HAI-Net) publishes a new version of the software application HelicsWin.Net.
World Tuberculosis Day - 24 March 2016
Marked each year on 24 March, World Tuberculosis Day gives the occasion to raise awareness about tuberculosis (TB) and to advocate more efforts to eliminate it. ECDC has launched the latest surveillance data and materials on interventions addressing vulnerable groups.
Hand Hygiene Day - SAVE LIVES: Clean Your Hands
Each year on 5 May, the “SAVE LIVES: Clean Your Hands” campaign takes place as part of a major global effort led by the World Health Organization (WHO) to improve hand hygiene in healthcare settings.
Investing in HIV response essential to curb on-going HIV transmission in Europe.Archived
New data for 2011 show that more than 121 000 new HIV cases were reported in the WHO European Region, including more than 28 000 new infections in the European Union and the European Economic Area (EU/EEA), indicating an increase for the whole Region compared to the previous year1.
Expert panel reviews neuraminidase inhibitors for the prevention and treatment of influenza
An ECDC expert opinion concludes that there is clear evidence supporting the use of neuraminidase inhibitors in the treatment and prevention of influenza. Moreover, the current recommendations in European countries on the use of the neuraminidase inhibitors oseltamivir and zanamivir are appropriate and should be applied by prescribing physicians.
The benefits of HIV treatment: undetectable means you do not pass on the virus
Since its introduction in the 1990s, the main aim of combination antiretroviral therapy (ART) for HIV has been to halt the progression of the infection, maintaining the health of the HIV-positive person taking treatment. In addition to this, the impact of treatment as prevention has been well described.